Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 51248-35-2
2. H-dl-leu-nca
3. L-leucine Nca
4. 4-(2-methylpropyl)-1,3-oxazolidine-2,5-dione
5. Isobutyloxazolidine-2,5-dione
6. (r,s)-4-isobutyloxazolidine-2,5-dione
7. Mfcd02684167
8. 26334-33-8
9. 51018-87-2
10. N-carboxyanhydride L-leucine; N-carboxyleucine Anhydride; Nsc 351903
11. Leucine Anhydride
12. Dl-leucine Nca
13. Mfcd03411292
14. Einecs 257-083-3
15. L-leucine N-carboxyanhydride
16. 3,3,3-triphenylpropionicacid
17. Schembl8647155
18. Dtxsid60871738
19. Act14057
20. Bca24835
21. Einecs 221-692-2
22. Dl-4-isobutyloxazolidine-2,5-dione
23. Mfcd03411293
24. Nsc351903
25. 2, 4-(2-methylpropyl)-, (s)-
26. Akos006228712
27. Nsc 351903
28. Nsc-351903
29. Sb44325
30. Ds-17234
31. Sy007693
32. Sy037764
33. Sy225253
34. Db-020426
35. Cs-0317706
36. Ft-0605180
37. Ft-0690463
38. Ft-0762388
39. J-650064
| Molecular Weight | 157.17 g/mol |
|---|---|
| Molecular Formula | C7H11NO3 |
| XLogP3 | 1.3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 2 |
| Exact Mass | 157.07389321 g/mol |
| Monoisotopic Mass | 157.07389321 g/mol |
| Topological Polar Surface Area | 55.4 Ų |
| Heavy Atom Count | 11 |
| Formal Charge | 0 |
| Complexity | 188 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A L-Leu-NCA manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of L-Leu-NCA, including repackagers and relabelers. The FDA regulates L-Leu-NCA manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. L-Leu-NCA API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A L-Leu-NCA supplier is an individual or a company that provides L-Leu-NCA active pharmaceutical ingredient (API) or L-Leu-NCA finished formulations upon request. The L-Leu-NCA suppliers may include L-Leu-NCA API manufacturers, exporters, distributors and traders.
L-Leu-NCA Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of L-Leu-NCA GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right L-Leu-NCA GMP manufacturer or L-Leu-NCA GMP API supplier for your needs.
A L-Leu-NCA CoA (Certificate of Analysis) is a formal document that attests to L-Leu-NCA's compliance with L-Leu-NCA specifications and serves as a tool for batch-level quality control.
L-Leu-NCA CoA mostly includes findings from lab analyses of a specific batch. For each L-Leu-NCA CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
L-Leu-NCA may be tested according to a variety of international standards, such as European Pharmacopoeia (L-Leu-NCA EP), L-Leu-NCA JP (Japanese Pharmacopeia) and the US Pharmacopoeia (L-Leu-NCA USP).
LOOKING FOR A SUPPLIER?
